Literature DB >> 12393774

Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery.

P-G Chassot1, A Delabays, D R Spahn.   

Abstract

The increasing number of patients with coronary artery disease undergoing major non-cardiac surgery justifies guidelines concerning preoperative evaluation, stress testing, coronary angiography, and revascularization. A review of the recent literature shows that stress testing should be limited to patients with suspicion of a myocardium at risk of ischaemia, and coronary angiography to situations where revascularization can improve long-term survival. Recent data have shown that any event in the coronary circulation, be it new ischaemia, infarction, or revascularization, induces a high-risk period of 6 weeks, and an intermediate-risk period of 3 months. A 3-month minimum delay is therefore indicated before performing non-cardiac surgery after myocardial infarction or revascularization. However, this delay may be too long if an urgent surgical procedure is requested, as for instance with rapidly spreading tumours, impending aneurysm rupture, infections requiring drainage, or bone fractures. It is then appropriate to use perioperative beta-block, which reduces the cardiac complication rate in patients with, or at risk of, coronary artery disease. The objective of this review is to offer a comprehensive algorithm to help clinicians in the preoperative assessment of patients undergoing non-cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393774

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  20 in total

Review 1.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Authors:  P J Devereaux; Lee Goldman; Deborah J Cook; Ken Gilbert; Kate Leslie; Gordon H Guyatt
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

2.  [Hip surgery immediately following stent revascularization of an acute myocardial infarction].

Authors:  A M Mathes; I Riemer; A Link; H Rensing
Journal:  Anaesthesist       Date:  2007-03       Impact factor: 1.041

3.  A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.

Authors:  Hanna E Teasley; Munseok Paul Jeong; Tae Hoon Kim
Journal:  Biochem Biophys Res Commun       Date:  2019-02-14       Impact factor: 3.575

4.  [Limitation of operability. What does the internist need to know?].

Authors:  M Reppel; J Weil
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

5.  Preoperative evaluation and treatment of stable CAD in patients scheduled for major elective vascular surgery.

Authors:  Rosemary F Kelly; Edward O McFalls
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-02

6.  Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency.

Authors:  Xuchen Ma; Fangjiong Huang; Zhitai Zhang; Feiqiang Song; Songlei Ou
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 7.  [Premedication visits. Economizing at the cost of the patient?].

Authors:  C D Kratz; M Christ; B Maisch; K M Kerwat; C Olt; A Zielke; A Hellinger; H Wulf; G Geldner
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

8.  Preoperative evaluation and preparation for anesthesia and surgery.

Authors:  A Zambouri
Journal:  Hippokratia       Date:  2007-01       Impact factor: 0.471

9.  The incidence of myocardial injury following post-operative Goal Directed Therapy.

Authors:  Rupert M Pearse; Deborah Dawson; Jayne Fawcett; Andrew Rhodes; R Michael Grounds; David Bennett
Journal:  BMC Cardiovasc Disord       Date:  2007-03-19       Impact factor: 2.298

10.  Risk factors for delay in surgery for patients undergoing elective anterior cervical discectomy and fusion.

Authors:  Sean P Renfree; Justin L Makovicka; Andrew S Chung
Journal:  J Spine Surg       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.